http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0670726-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ca7793d461956996baa08d28aa51c9e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55588 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate | 1994-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61e5f52c1fd3c9f694c2b48afc6e56e6 |
| publicationDate | 1995-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0670726-A1 |
| titleOfInvention | Treatment of hiv infection with humic acid |
| abstract | The present invention discloses the use of natural, commercially available Humic Acid preparations in the treatment of human immunodeficiency virus (HIV) through its demonstrated anti-HIV-1 effect, anti-syncytia formation effect and/or immunostimulation of IL-2. The Humic Acid preparations hereof are thus useful in the treatment of HIV and AIDS and are described as particularly useful alone or as adjuvants to be co-administered in immunovaccinations against HIV. |
| priorityDate | 1993-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.